Organization
PDL BioPharma, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on PDL BioPharma, Inc.

... A provider of secure data access and management solutions for IoT assets.PDL BioPharma, Inc. A owner of royalty rights, debt securities and other assets in ...
... Biotechnology royalty company PDL BioPharma Inc (NASDAQ:PDLI) disclosed on Monday the election of Edward Imbrogno as vice ...
... INCLINE VILLAGE - PDL BioPharma, Inc. ('PDL' or the 'Company') (NASDAQ: PDLI) announces that John McLaughlin, PDL's ...
... PR Newswire PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that John McLaughlin, PDL's ...
... PDL BioPharma, Inc. ("PDL") (NASDAQ: PDLI) announces its Board of Directors has authorized a ...
... a long-only public equity investment firm and significant shareholder in PDL BioPharma, Inc. (NasdaqGS: PDLI) ("PDL" or the "Company") with 2,590,198 shares of common stock, ...
... PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) announces that John McLaughlin, PDL's ...
... Collaboration and License Agreements: On August 2, 2018, the Company sold to PDL BioPharma, for $ 20 million in cash, the Company's remaining interest in ...
... PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ: PDLI) reports financial results for the ...
Subscribe now for full coverage on PDL BioPharma, Inc.
Start My Free Trial